CMS Offers First Look at Medicare Prescription Drug Inflation Rebate Program
- February 10, 2023
The Centers for Medicare & Medicaid Services (CMS) issued February 9 guidance to implement provisions of the Inflation Reduction Act (IRA) that require drug manufacturers to pay rebates to Medicare if their prices increase faster than inflation.
ARTICLE TAGS
You must be logged in to access this content.